{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:55:57Z","timestamp":1789973757116,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The American Autoimmune Related Disease Association, and Mr. and Mrs. Joseph Scoby and the Gail I Zuckerman Foundations"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41423-018-0087-y","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T12:30:45Z","timestamp":1532089845000},"page":"706-717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity"],"prefix":"10.1038","volume":"16","author":[{"given":"Merylin","family":"Cottagiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"Nyandjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-7231","authenticated-orcid":false,"given":"Joel J.","family":"Mantilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel R.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5458-4596","authenticated-orcid":false,"given":"Dolores B.","family":"Njoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"87_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1055\/s-0029-1240002","volume":"29","author":"LN Bell","year":"2009","unstructured":"Bell, L. N. & Chalasani, N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 29, 337\u2013347 (2009).","journal-title":"Semin Liver Dis."},{"key":"87_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/978-1-4684-5134-4_61","volume":"197","author":"H Satoh","year":"1986","unstructured":"Satoh, H. et al. Investigation of the immunological basis of halothane-induced hepatotoxicity. Adv. Exp. Med. Biol. 197, 657\u2013673 (1986).","journal-title":"Adv. Exp. Med. Biol."},{"key":"87_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1021\/tx960083q","volume":"9","author":"M Bourdi","year":"1996","unstructured":"Bourdi, M. et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem. Res. Toxicol. 9, 1159\u20131166 (1996).","journal-title":"Chem. Res. Toxicol."},{"key":"87_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.yexmp.2004.10.004","volume":"78","author":"DB Njoku","year":"2005","unstructured":"Njoku, D. B. et al. A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB\/c mouse. Exp. Mol. Pathol. 78, 87\u2013100 (2005).","journal-title":"Exp. Mol. Pathol."},{"key":"87_CR5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/eji.200838135","volume":"39","author":"DB Njoku","year":"2009","unstructured":"Njoku, D. B. et al. Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury. Eur. J. Immunol. 39, 1652\u20131663 (2009).","journal-title":"Eur. J. Immunol."},{"key":"87_CR6","doi-asserted-by":"publisher","first-page":"e61186","DOI":"10.1371\/journal.pone.0061186","volume":"8","author":"J Cho","year":"2013","unstructured":"Cho, J. et al. Sex bias in experimental immune-mediated, drug-induced liver injury in BALB\/c mice: suggested roles for Tregs, estrogen, and IL-6. PLoS ONE 8, e61186 (2013).","journal-title":"PLoS ONE"},{"key":"87_CR7","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.jss.2010.04.004","volume":"163","author":"GA Roth","year":"2010","unstructured":"Roth, G. A. et al. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure. J. Surg. Res. 163, e79\u2013e83 (2010).","journal-title":"J. Surg. Res."},{"key":"87_CR8","first-page":"819636","volume":"2012","author":"J Wang","year":"2012","unstructured":"Wang, J., Zhao, P., Guo, H., Sun, X., Jiang, Z., Xu, L. et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediat. Inflamm. 2012, 819636 (2012).","journal-title":"Mediat. Inflamm."},{"key":"87_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/jir.2011.0109","volume":"32","author":"J Wang","year":"2012","unstructured":"Wang, J. et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. J. Interferon Cytokine Res. 32, 248\u2013253 (2012).","journal-title":"J. Interferon Cytokine Res."},{"key":"87_CR10","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/hep.25768","volume":"56","author":"N Sakai","year":"2012","unstructured":"Sakai, N. et al. Interleukin-33 is hepatoprotective during liver ischemia\/reperfusion in mice. Hepatology 56, 1468\u20131478 (2012).","journal-title":"Hepatology"},{"key":"87_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","volume":"39","author":"T McHedlidze","year":"2013","unstructured":"McHedlidze, T. et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39, 357\u2013371 (2013).","journal-title":"Immunity"},{"key":"87_CR12","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1172\/JCI73742","volume":"124","author":"J Li","year":"2014","unstructured":"Li, J. et al. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J. Clin. Invest. 124, 3241\u20133251 (2014).","journal-title":"J. Clin. Invest."},{"key":"87_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12026-012-8283-9","volume":"52","author":"M Milovanovic","year":"2012","unstructured":"Milovanovic, M. et al. IL-33\/ST2 axis in inflammation and immunopathology. Immunol. Res. 52, 89\u201399 (2012).","journal-title":"Immunol. Res."},{"key":"87_CR14","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/hep.25893","volume":"56","author":"MI Arshad","year":"2012","unstructured":"Arshad, M. I. et al. TRAIL but not FasL and TNFalpha, regulates IL-33 expression in murine hepatocytes during acute hepatitis. Hepatology 56, 2353\u20132362 (2012).","journal-title":"Hepatology"},{"key":"87_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2011.03.022","volume":"56","author":"V Volarevic","year":"2012","unstructured":"Volarevic, V. et al. Protective role of IL-33\/ST2 axis in Con A-induced hepatitis. J. Hepatol. 56, 26\u201333 (2012).","journal-title":"J. Hepatol."},{"key":"87_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","volume":"513","author":"C Schiering","year":"2014","unstructured":"Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564\u2013568 (2014).","journal-title":"Nature"},{"key":"87_CR17","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","volume":"193","author":"BM Matta","year":"2014","unstructured":"Matta, B. M. et al. IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2+ regulatory T cells. J. Immunol. 193, 4010\u20134020 (2014).","journal-title":"J. Immunol."},{"key":"87_CR18","doi-asserted-by":"publisher","first-page":"G313","DOI":"10.1152\/ajpgi.00097.2016","volume":"311","author":"G Noel","year":"2016","unstructured":"Noel, G. et al. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration. Am. J. Physiol. Gastrointest. Liver Physiol. 311, G313\u2013G323 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"87_CR19","doi-asserted-by":"publisher","first-page":"e0161507","DOI":"10.1371\/journal.pone.0161507","volume":"11","author":"J Siede","year":"2016","unstructured":"Siede, J. et al. IL-33 receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGFbeta release. PLoS ONE 11, e0161507 (2016).","journal-title":"PLoS ONE"},{"key":"87_CR20","doi-asserted-by":"publisher","first-page":"9429760","DOI":"10.1155\/2016\/9429760","volume":"2016","author":"M Ryba-Stanislawowska","year":"2016","unstructured":"Ryba-Stanislawowska, M., Werner, P., Skrzypkowska, M., Brandt, A. & Mysliwska, J. IL-33 effect on quantitative changes of CD4+CD25highFOXP3+ regulatory T cells in children with type 1 diabetes. Mediat. Inflamm. 2016, 9429760 (2016).","journal-title":"Mediat. Inflamm."},{"key":"87_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1398-9995.2011.02735.x","volume":"67","author":"YH Kim","year":"2012","unstructured":"Kim, Y. H. et al. Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy 67, 183\u2013190 (2012).","journal-title":"Allergy"},{"key":"87_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/01902148.2013.870261","volume":"40","author":"HY Lee","year":"2014","unstructured":"Lee, H. Y. et al. Blockade of IL-33\/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp. Lung Res. 40, 66\u201376 (2014).","journal-title":"Exp. Lung Res."},{"key":"87_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2008.11.003","volume":"32","author":"DB Njoku","year":"2009","unstructured":"Njoku, D. B. et al. IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis. J. Autoimmun. 32, 52\u201359 (2009).","journal-title":"J. Autoimmun."},{"key":"87_CR24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/MPG.0b013e3182250651","volume":"53","author":"SI Lopez","year":"2011","unstructured":"Lopez, S. I. et al. Autoimmune hepatitis type 2 in a child with IPEX syndrome. J. Pediatr. Gastroenterol. Nutr. 53, 690\u2013693 (2011).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"87_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-230X-12-92","volume":"12","author":"P Invernizzi","year":"2012","unstructured":"Invernizzi, P. et al. Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterol. 12, 92 (2012).","journal-title":"BMC Gastroenterol."},{"key":"87_CR26","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jaci.2010.06.038","volume":"126","author":"HR Kim","year":"2010","unstructured":"Kim, H. R. et al. Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia. J. Allergy Clin. Immunol. 126, 880\u2013882 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"87_CR27","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.4049\/jimmunol.1300117","volume":"190","author":"Y Liang","year":"2013","unstructured":"Liang, Y., Jie, Z., Hou, L., Aguilar-Valenzuela, R., Vu, D., Soong, L. et al. IL-33 induces nuocytes and modulates liver injury in viral hepatitis. J. Immunol. 190, 5666\u20135675 (2013).","journal-title":"J. Immunol."},{"key":"87_CR28","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1073\/pnas.1003059107","volume":"107","author":"K Oboki","year":"2010","unstructured":"Oboki, K. et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl Acad. Sci. USA 107, 18581\u201318586 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"87_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/intimm\/dxr006","volume":"23","author":"J Louten","year":"2011","unstructured":"Louten, J. et al. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. Int Immunol. 23, 307\u2013315 (2011).","journal-title":"Int Immunol."},{"key":"87_CR30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","volume":"123","author":"MA Rank","year":"2009","unstructured":"Rank, M. A. et al. IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol. 123, 1047\u20131054 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"87_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva, M. & O\u2019Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170\u2013181 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"87_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jaut.2014.01.032","volume":"50","author":"S Sattler","year":"2014","unstructured":"Sattler, S. et al. IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut. J. Autoimmun. 50, 107\u2013122 (2014).","journal-title":"J. Autoimmun."},{"key":"87_CR33","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/hep.27253","volume":"60","author":"MJ Kurth","year":"2014","unstructured":"Kurth, M. J., Yokoi, T. & Gershwin, M. E. Halothane-induced hepatitis: paradigm or paradox for drug-induced liver injury. Hepatology 60, 1473\u20131475 (2014).","journal-title":"Hepatology"},{"key":"87_CR34","first-page":"153","volume":"2","author":"H Jaeschke","year":"2014","unstructured":"Jaeschke, H., Xie, Y. & McGill, M. R. Acetaminophen-induced liver injury: from animal models to humans. J. Clin. Transl. Hepatol. 2, 153\u2013161 (2014).","journal-title":"J. Clin. Transl. Hepatol."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0087-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0087-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0087-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:21:16Z","timestamp":1684617676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-018-0087-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1038\/s41423-018-0087-y","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"11 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ms. Cottagiri declares no potential conflict of interest. Ms Nyandjo declares no potential conflict of interest. Mr. Stephens declares no potential conflict of interest. Mr. Mantilla declares no potential conflict of interst. Dr. Saito declares no potential conlict of interest. Dr. Mackay delarees no potential conflict of interest. Dr. Rose declares no potential conflict of interest. Dr. Njoku owns a patent on the epitope utilized in this manuscript. There are no financial relationships or compensations associated with this patent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}